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Abstract
The rapid increase in volume and complexity of biomedical data requires
changes in research, communication, and clinical practices. This includes
learning how to effectively integrate automated analysis with high–data den-
sity visualizations that clearly express complex phenomena. In this review,
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we summarize key principles and resources from data visualization research that help address
this difficult challenge. We then survey how visualization is being used in a selection of emerg-
ing biomedical research areas, including three-dimensional genomics, single-cell RNA sequenc-
ing (RNA-seq), the protein structure universe, phosphoproteomics, augmented reality–assisted
surgery, and metagenomics. While specific research areas need highly tailored visualizations,
there are common challenges that can be addressed with general methods and strategies. Also
common, however, are poor visualization practices. We outline ongoing initiatives aimed at im-
proving visualization practices in biomedical research via better tools, peer-to-peer learning, and
interdisciplinary collaboration with computer scientists, science communicators, and graphic de-
signers. These changes are revolutionizing how we see and think about our data.
The eye of a Master, will do more Work than his Hand.
—Benjamin Franklin, Poor Richard’s Almanack (1744)
INTRODUCTION
The launch of this Annual Reviews journal is driven by the rapid increase in volume and complex-
ity of biomedical data, requiring changes in research, communication, and clinical practices (1).
Without these changes, many biomedical discoveries will remain buried in data already collected,
and many misdiagnoses (now estimated at ∼10–30% of all diagnoses) will remain unrecognized
(2, 3), contributing to a major cause of death (4).
These changes in practice will include the development and adoption of new, automated analysis
methods (e.g., clustering, modeling, machine learning). However, while necessary (Figure 1a),
automated analysis is not sufficient: As demonstrated by Anscombe’s quartet (Figure 1b), to find
the truth, we need to visually inspect all relevant data and analyses together. Driven by this
realization, data visualization has been a major research focus in computer science for decades
(see the sidebar titled Data Visualization, SciVis, and InfoVis), yielding many resources that could
accelerate discovery in biomedical research (5–9).
Unfortunately, relatively few scientists currently use these resources. This is evident, for ex-
ample, from the widespread use of rainbow color maps (found in >50% of papers in a survey of
research publications containing scientific visualizations; 10). While seemingly inconsequential,
visualization research has shown that rainbow maps can obfuscate true data patterns and introduce
visual artifacts (10). Sadly, many biomedical data sets (often difficult or expensive to acquire) are
inspected using poor visualization methods, even though better alternatives are known.
Similarly, visualization methods are underutilized by clinicians, contributing to misdiagnoses.
About half of all diagnostic errors arise from faulty cognitive processing of data (2); many of these
errors can be addressed by improving how data are visualized (11). This is especially true in fields
of medicine, such as radiology, where the core data are intrinsically visual, and diagnosis depends
largely on visual perception (3).
We believe that the underuse of visualization methods has arisen largely because of the follow-
ing misconceptions we often encounter.
Misconception 1: “The goal of data visualization is to impress.” We sometimes think of data
visualization as purely aesthetic, adding an optional wow factor not present in the data itself. This
can be true when creating artwork (e.g., a cover figure), but the role of data visualization in research
is almost exactly the opposite: It is a necessary step, aimed at clearly revealing patterns in data.
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Figure 1
Role of data visualization in research. (a) As shown in this simplified model of the research workflow, data
visualization is often a necessary and rate-limiting step in both discovery and communication. (b) Anscombe’s
quartet (117, 118) is a set of four two-dimensional data sets in which X and Y values have identical mean,
variance, and correlation coefficient. They also fit an identical linear regression line (orange) with an identical
coefficient of determination. Based on these statistics alone, we might expect all plots to be similar to the
first, but visualization reveals surprisingly distinct patterns in each data set. This demonstrates that we
cannot skip from analysis to discovery: It is almost always necessary to confirm insights from automated
analysis by manually visualizing data. Panel a adapted from Reference 119. Panel b adapted with permission
from Reference 117.
Misconception 2: “Data visualization is easy.” Well-designed visualizations can be so easy to
understand and use that we are misled into thinking they must have been easy to create. However:
“Most graphs are simple, but their invention was neither simple nor obvious—the idea did not
occur to the Greeks or Romans, nor even to the great 17th century mathematician-experimenters
such as Newton and Leibniz” (12, p. 201).
Misconception 3: “Studying data visualization is unnecessary.” Underestimating the difficulty
of data visualization can lead us to overestimate our current skills and conclude that we would gain
little benefit from investing time, effort, or money in training or study.
Misconception 4: “Visualization is just a synonym for imaging.” In the life sciences, “visu-
alization” is often used as a synonym for “imaging experiments.” In computer science, “data
visualization” has a much broader meaning: In addition to imaging data, it encompasses abstract
data, interactive analysis, design, as well as visual and cognitive abilities. Furthermore, its purpose
is insight, not pictures (9).
DATA VISUALIZATION, SciVis, AND InfoVis
Computer scientists have long used the term “scientific visualization” (or “SciVis”) to describe visualization of data
that directly map into two or three spatial dimensions (e.g., cartography, computed tomography scans). In contrast,
the term “information visualization” (or “InfoVis”) is used to describe visualization of abstract data (e.g., classic
two-dimensional data plots, network graphs). Since around the year 2000, “data visualization” has emerged as a
unifying term that encompasses both of these historically separated research fields.
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AVOIDING COMMON VISUALIZATION MISTAKES
Biomedical data sets are often difficult and expensive to acquire and analyze. Ironically, when these data are vi-
sualized, we often use techniques that obfuscate true patterns in our data and introduce visual artifacts. To avoid
the most common mistakes, we recommend the following strategies. (a) Avoid rainbow color maps (10, 110).
(b) Use color minimally (111); color used poorly is worse than no color at all (112). (c) Avoid creating confusing, over-
crowded visualizations (e.g., hairball graphs); reduce information via filtering or clustering or use a different layout
(Figure 7). (d ) Use three-dimensional (3D) visualizations only for spatial data that is intrinsically 3D, e.g., macro-
molecular structures (113), and avoid using 3D visualizations for abstract data. (e) Avoid conflating research and art.
Many of the commonly used tailored tools provide powerful features that make it easy to create visualizations that
are dramatic or aesthetically appealing but where the underlying scientifically meaning becomes obscured. This can
be useful when creating impactful artwork (e.g., a cover figure), but it undermines the goals of data visualization in
research, which are always clarity and insight.
Data density: the
total number of data
entries shown in a
visualization divided





data (e.g., using color




clarity with which a
given visual encoding
of data is conveyed to
the reader
Below, we outline some key data visualization principles, many of which are straightforward,
helping to create better visualizations and avoid common mistakes (see the sidebar titled Avoiding
Common Visualization Mistakes). We then survey a selection of emerging biomedical research
areas where visualization is playing a key role. Finally, we discuss how visualization can enhance
biomedical communication and, in conclusion, we consider prospects for improving the global
standard of data visualization in biomedical research.
DATA VISUALIZATION PRINCIPLES
Data Volume
How can data visualization help us deal with the increasingly large volume of biomedical data sets?
One straightforward answer is to get more pixels. Our visual system has extraordinary capacity
and can manage much more information than is presented in many of the scientific visualizations
we currently create. Information transfer speed from the eye to the brain is about 10 Mb/s,
similar to wired internet (13), and well-encoded visual patterns can be recognized within 250 ms
(preattentatively) (14). Larger, higher-resolution displays can help use more of our visual capacity.
For example, connecting a laptop to a 4K display can be a cost-effective way to see more detail
and improve navigation and work efficiency (15). However, larger displays become increasingly
less cost effective and often have impractical user interface controls. In addition, scaling up a
visualization can make global patterns (e.g., correlation) harder to perceive (16)—clearly, there is
an optimal size range for visualizations.
Therefore, a second answer is to create visualizations with greater data density. Here again,
our visual system has greater capacity than we typically use: Aided by redundancy and context,
the eye can resolve features to 0.1 mm (5). Thus, many visualization researchers advocate creating
visualizations with high data density, often a practical requirement in high-impact journals due to
space limitations (5). Creating compact visualizations requires carefully selecting visual channels
that encode data with high visual effectiveness. Fortunately, visualization research provides clear
guidelines for this (Figure 2). Also required is time and effort to learn specialist tools (Table 1)
that provide precise controls necessary for visualizing large data volumes with high data density.
However, there are limits: As data density increases, visualizations can require specific, targeted
strategies to remain effective (17).
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Quantitative/ordered data Categorical data
Color hue
Avoid rainbow color maps
0 1.0–1.0
Use divergent color map for low/high data
0.5 1.00
Use luminance/saturation for monotonic data
Rainbow maps add artifacts and hide details
Additional visual channels (unranked): connection, containment/enclosure, crispness/resolution, flicker, 
line endings, line pattern, line weight, numerosity, text, texture, transparency, weight/boldness.
Figure 2
Visual channel ranking, showing the most- to least-effective visual channels (top to bottom, respectively) for encoding quantitative/
ordered or categorical data. These rankings can be a useful guide in designing new visualizations and in studying exemplary
visualizations (e.g., Figures 3 and 7a). Unfortunately, the use of color hue to encode quantitative data is still widespread in science even
though visualization research clearly demonstrates that this can be not only ineffective but also harmful, introducing visual artifacts and
hiding details (10). Instead (bottom right inset), it is more effective to use color maps tailored for specific data ranges (120). Figure
adapted with permission from Reference 8, based on the approach pioneered by Mackinlay (121) and extended by others (107).
Data Complexity
In many ways, big data volume is a small problem in the life sciences. Far more challenging is
the complexity of our data, which are often multivariate, multiscale, highly interconnected, and
dependent on very specific conditions.
Here, a common strategy is to use analytical methods to reduce dimensionality (e.g., clustering,
principal component analysis). However, Anscombe’s quartet (Figure 1b) reminds us that we need
to visually inspect all relevant data before we draw conclusions from a simplified subset, and very
often we require many more than two variables to express the complex phenomena studied in
biomedical data sets.
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Table 1 Data visualization resources recommended for biomedical scientists in any fielda
Resource Description URL
Discoveryb
Excelc Everyday tool for generic visualization of smaller data sets http://microsoft.com/excel
Plotly Online tool for fast data visualization https://plot.ly/create/
Tableauc For interactive visualizations, including web based http://tableau.com
Spotfirec For visual analysis of larger data sets and tool generation https://spotfire.tibco.com/
Originc,d For visual analysis of larger data sets http://originlab.com
Mathematicac For visual analysis of data sets and mathematical functions http://wolfram.com
MATLABc For visual analysis of data sets and mathematical functions http://mathworks.com
Matplotlib For tailored visualizations of data sets in Python (115) http://matplotlib.org
ggplot2 For tailored visualizations of large, complex data sets in R (116) http://ggplot2.org
D3.js For tailored, interactive web-based visualizations https://d3js.org
Communication
Photoshopc For editing imaging data http://adobe.com/photoshop
GIMP Free, open source alternative to Photoshop http://www.gimp.org
Illustratorc For creating and editing vector graphics http://adobe.com/illustrator
Inkscape Free, open-source alternative to Illustrator http://inkscape.org
MolecularMaya Molecular structure plug-in for Autodesk Mayac animation suite http://bit.ly/molmaya
BioBlender Molecular structure plug-in for Blender animation suit http://bioblender.org
Utilities
Color Brewer Web tool for selecting contrasting color maps http://colorbrewer2.org
Adobe Color Web tool for designing sets of colors http://color.adobe.com
Paletton Web tool for designing sets of colors http://paletton.com
General Resources
BioVis Computer science publications on biological visualizations http://biovis.net
Clarafic Training guides for biomedical visualization tools http://clarafi.com
Information is Beautiful Showcase of charts and infographics for a wide variety of data http://bit.ly/Info_Beauty
Visual Complexity Catalog of tailored visualizations for complex data http://visualcomplexity.com
VIZBI Collected videos and posters on tailored biological visualizations http://vizbi.org
Exemplars
PDB101 Outstanding visual explanations of protein function and structure https://pdb101.rcsb.org
Roche pathway Tailored visualization showing ∼3,000 metabolic reactions (72) http://bit.ly/RochePathway
WEHI.tv Collection of inspiring, informative biomedical animations http://wehi.tv
aThis table covers only tools and online resources; published articles and books describing generally useful visualization methods are highlighted as
annotated references in the Literature Cited. Visualization methods tailored for specific fields of biomedical research are given in the section titled
Visualization for Discovery.
bArranged in approximate order, starting at the top with easy-to-use, everyday tools for generic, one-off visualization tasks and progressing to tools that
require more time and effort to use but that can manage large, complex data or reoccurring tasks.
cThese tools cost money to use; the rest are free.
dRequires Microsoft Windows.
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Remarkably, multivariate data of any dimensionality can be visualized in two dimensions with-
out loss of information, using a range of generic methods (Figure 3a–d) and tools (Table 1).
However, multidimensional data patterns are often scrambled and hard to recognize or interpret
when encoded into two dimensions (18).
Data Integration and Tailored Visualizations
Clearly revealing these multidimensional patterns usually requires carefully tailored visualizations
that use very specific data integration strategies. Figure 3e reproduces an exemplary tailored
visualization created by Charles Minard in 1869, showing Napoleon’s disastrous Russian campaign
(5). To learn how to make better visualizations, readers should study in detail (guided by Figure 2)
how this complex, multivariate data story has been communicated so clearly and concisely. For
example, Minard’s graph shows that tailored visualizations sometimes require using less effective
channels: In Figure 3e, army size would be more effectively encoded using a bar chart, but
this would not be as visually expressive. Similarly, it can sometimes be required to break visual
conventions: In Figure 3e, the bottom plot implicitly shows time flowing right to left, with
irregularly spaced dates. Despite these departures from recommended guidelines, Minard’s graph
has been described as perhaps “the best statistical graph ever drawn” (5, p. 40).
While generic visualization methods (Figure 3a–d) and tools are frequently used in biomedical
research, tailored visualizations are the mainstay. Creating them requires three inter-related steps.
(a) First, identify the necessary complexity. This is the subset of data that can visually express all, and
only, information of most relevance to the phenomena studied. This usually means excluding data
(e.g., in Figure 3e, temperature is shown only when it caused significant losses) or showing only
derived features (e.g., principal components). (b) Second, identify necessary supporting context.
This often means adding related information not part of the initial data set (e.g., in Figure 3e,
geographic features help interpret the data set). (c) Third, invent a visual strategy that coherently
integrates these data, using effective visual encoding and conventions familiar to peers.
A successful tailored visualization arranges all relevant data into a compact, immediately ac-
cessible two-dimensional (2D) view. This facilitates spatial reasoning, which, in turn, reduces the
cognitive load needed to read a visualization and gain insight from data (19). By using familiar
or intuitive visual conventions, successful visualization strategies also reduce the cognitive load
needed when first learning to how to read them.
Fortunately, for many of the data challenges faced in biomedical research (20–24), tailored
visualization methods have already been invented and implemented into working tools. These
tools often use interactivity (25, 26) to facilitate combined exploration and integration of raw data,
data derived via analysis, and additional supporting evidence.
However, cutting-edge research often requires us to invent novel, tailored visualizations. This
difficult task can be aided by drawing ideas and inspiration from visualization resources (see
Table 1 and the Annotated References 1, 5–9, 27, and 28) and by learning from peers facing
similar challenges. Thus, the next section surveys tailored visualizations being used to reveal new
insights across a broad range of biomedical research areas.
VISUALIZATION FOR DISCOVERY
Genomics and Epigenetics
We begin this survey in the field of genomics and epigenetics, where rapid advances in DNA
sequencing technologies are generating a flood of data. These data are not just limited to raw
DNA sequences but include an increasing spectrum of additional information that can be obtained
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French army losses during Napoleon’s Russian campaign (1812–1813)
Redrawn from original by Charles Minard (1869). Graph width indicates deaths and desertions as the 
army of initially 422,000 soldiers reduced to 10,000. Beige coloring shows advance into Russia. Black 
shows retreat, for which temperature is also plotted (below).
G R A P H I C  C H A R T  o f  b e l o w - z e r o  t e m p e r a t u r e s  i n  C e l s i u s  s c a l e    
T h e  C o s s a c k s  g a l l o p  o v e r  
t h e  f r o z e n  N i e m e n  
French league (map of  Mr.  de Fezensac)
Oct. 24
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Minimal coloring Supporting contextMetadata
a  Data matrix
e  Tailored visualization








Different two-dimensional (2D) views of a 4D data set. (a) Showing a data matrix as text reveals all information in two dimensions, but
patterns can be difficult to detect. (b) In a heat map (122), the data matrix is visually encoded using color. This can give high data
density; however, revealing data patterns often requires reordering rows and columns. Unfortunately, optical illusions can mask true
patterns and introduce visual artifacts (47). (c) In parallel coordinate plots (18, 28), columns of the data matrix are represented as parallel
axes, and each row becomes a series of line segments joining the axes. Correlations between adjacent axes can be easy seen, but not
between nonadjacent axes. Hence, revealing data patterns often requires reordering axes and careful choice of a color map (here used to
show X values). Parallel coordinates can reveal patterns not easily seen in a heat map, but they are usually not as compact. (d ) A
scatterplot matrix shows every pairwise combination of columns in the data matrix, thus visualizing all 2D correlations. (e) An
exemplary tailored visualization of multivariate data, demonstrating many best practices. The return journey, shown here in black, uses
the same data in panels a–d. Only the most visually expressive parts of the scatterplot matrix in panel d (dotted line) have been included.
Note the use of very effective visual encodings (Figure 2), minimal use of color, and the addition of supporting context via geographic
features. Metadata establish credibility by identifying the author, evidence sources, and methods. Panel b was made with Microsoft
Excel, panels c and d were made with Matplotlib (115), and panel e was redrawn from Charles Minard’s original using Illustrator.
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genome wide. For example, single-molecule bisulphite sequencing can determine the methylation
state of every cytosine base, chromatin immunoprecipitation sequencing can map protein–DNA
interactions, and transposase-accessibility can be used to identify open regions of chromatin (29).
Together, this flood of data contains unprecedented detail into the molecular structure, regulation,
and function of whole organisms, but in a condensed, fragmented, and encoded form.
Visualization is widely used to help unravel this information: A very common task, and often
rate-limiting step, is manual browsing of features to gain insight into function (20). The linear
organization of chromosomes (Figure 4a) provides a natural visual layout, allowing many genomic
features to be positioned on a common horizontal scale (Figure 4b), thus using the most effective
visual channel (Figure 2).
Visualization challenges. A core challenge is multiscale navigation, both horizontally (across
hundreds of millions of base pairs) and vertically (since regions can contain thousands of over-
lapping genomic features). Current genome browsers (20, 30) address this fairly well, using the
general strategy of overview first, details upon demand (overview/details; 31). This strategy is
implemented using feature clustering methods for (e.g., ChromHMM; 32) and user interface
controls to help users find and explore specific genomic regions and features of interest while
maintaining awareness of overall chromosomal location and context (Figure 4b).
As new genomic technologies (e.g., single-cell or single-molecule DNA sequencing) continue
to produce data of rapidly increasing volume and complexity, further innovations are needed in
visualization methods. This includes improvements in multiscale navigation, error and uncertainty
visualization (e.g., arising from base calling, assembly, and finishing; 20), variant analysis (33),
and managing de novo assemblies for organisms where reference genomes are not available. In
addition, novel tailored visualizations need to be developed to address a wide range of important,
yet very specific biomedical topics, such as genomic rearrangements in cancer (34).
Emerging frontiers. An exciting frontier in genomics is the study of the 3D spatial organization
of chromosomes. An accurate, atomic-scale model of the genome is a grand challenge that may
someday be achieved thanks to recently developed experimental techniques (primarily Hi-C; 35)
that can determine spatial chromatin contacts between pairs of genomic regions. These methods
have low resolution and high false positive rates so cannot yet determine accurate 3D models
for chromosomes (36). Nonetheless, Hi-C data can give new insights, but interpreting these data
sets is difficult (37). Thus, tailored visualization methods are being developed, currently based
around three alternative views. In one, Hi-C data are shown as a contact matrix (Figure 4c),
allowing for high data density and a clear overview (38) but making it difficult to overlay other
genomic features. A pyramidal layout (Figure 4d) addresses this issue (39) but makes it harder to
see contacting regions. A circular layout (Figure 4e) is more compact (40), and using arcs to show
contacts is a more effective visual encoding (41), but this does not allow the same data density;
hence, only major contacts (calculated via clustering) are shown. Such tradeoffs between alternative
views of multidimensional data are common, with each viewpoint providing different insights.
These and other advances in genomics are gradually unraveling the remaining mysteries of
genomic function. Currently, however, we still lack an understanding of many core processes,
such as exactly what gets transcribed and when and how this is controlled in different cell types.
RNA Biology
RNA molecules play a leading role in biological systems, acting as messengers and sensors and
forming the ribosome, one of the most ancient molecular machines. Many researchers now focus
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Figure 4
Genomic features of human chromosome 2. (a) The linear organization of chromosomes provides a natural visual layout for mapping
genomic features such as cytobands, shown in this overview of a 240 megabase (Mb) chromosome. (b) Genome browsers enable
navigation to small, specific regions that often contain vast numbers of features, including epigenetic marks (H3K4me1, etc.), genes,
and regulatory elements. Graphical overviews for features are created with clustering methods such as ChromHMM (32), which
condense many features into a single track, using color to indicate regions with similar features. Genes are also used as a graphical
overview for the often large number of transcripts they encode, which can be revealed upon demand. (c) Some features do not fit a
linear layout; for example, Hi-C data (35), shown here, indicate three-dimensional spatial contacts between genomic regions and can be
encoded with color saturation and a contact matrix layout. (d ) Rotating the matrix and removing redundant contact data allows easier
comparison with other features. (e) Connecting arcs are a more effective visual encoding for spatial contacts, and a circular layout is
generally more compact. Panels a–e were made using Ensembl (123), Biodalliance (https://www.biodalliance.org; 124), JuiceBox (38),
WashU EpiGenome Browser (39), and Rondo (http://rondo.ws; 41), respectively, and modified in Illustrator. Data in panels c–e are
from Reference 125.
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Heat map: a graphical
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OPTICAL ILLUSIONS CAUSED BY GROUND SUBTRACTION
Visualizations that rely on color to encode quantitative values are subject to an optical illusion known as ground
subtraction. In a heat map, for example, strongly contrasting colors in a cell’s neighbors can make the cell appear
much higher or lower in luminance than it should. This illusion can be very strong; as demonstrated in the checker
shadow image by Edward H. Adelson (http://persci.mit.edu/gallery/checkershadow), the human visual system
can be surprisingly inaccurate at reading values encoded with color. In heat maps, this illusion can mask true patterns
and introduce visual artifacts (47). As the numbers of rows and columns increase or as cell size is reduced, the effect
can become worse, making it impractical to display all significant results as one very large heat map. Thus, for
the display of quantities where absolute variation between observations is important, it is recommended to encode
values with position or size rather than lightness, saturation, or color hue (Figure 2).
on unlocking the secrets of the RNA world; meanwhile, the measurement of RNA transcript
abundances has become the workhorse of modern biology. First accomplished with microarray
experiments (42), accurate measurements of the abundance of transcripts in biological samples
and single cells (43) are now taken with RNA sequencing (RNA-seq) (44).
Visualization challenges. Interpreting the high-dimensional data sets from RNA-seq experi-
ments remains challenging. After careful experimental design and statistical analysis (45), gene
expression values judged to be significant are commonly presented as clustered heat maps (46),
a technique that has dominated since the first microarray experiments (42). However, optical
illusions in these visualizations make it difficult to judge the magnitude of individual values or
fold changes between pairs of values (see the sidebar titled Optical Illusions Caused by Ground
Subtraction). As the numbers of rows and columns increase or cell size is reduced, these effects
become worse, making it impractical to display all significant results as one very large heat map.
Further problems arise because the rows and columns of clustered heat maps are usually ordered
to group associated genes and conditions and so highlight regulatory effects (47). Inevitably, values
for genes and conditions without significant association will be placed next to one another, which
exacerbates perceptual problems. Separating unrelated rows and columns (Figure 5a) can help,
but this does not fundamentally address these difficulties (48), particularly for genes that cluster
poorly. In such cases, there may be insufficient data to resolve those genes’ regulatory networks
as a 1D ordering, so it is important that the degree and support for relationships inferred from
clustering are also shown. The addition of tree graphs, however, further constrains the size of the
heat map that can be displayed without issue,1 so we suggest that only the most informative subset
of genes and conditions should be presented in this way.
Emerging frontiers. Single-cell RNA-seq experiments (scRNA-seq) are a revolutionary new
technology that can reveal key events in differentiation normally masked in bulk RNA-seq exper-
iments, thus providing deep insight into the behavior of cells and tissues. These data are typically
visualized using dimensionality reduction methods that allow gene expression vectors to be pro-
jected onto 2D scatterplots (Figure 5b–d). scRNA-seq data allow the sequence of these events
to be reconstructed—commonly termed cell pseudotime (49). Clustering and dimensionality
1We recommend rectangular heat map cells of no less than 6 mm, separated by 1.5 mm, and overlaid on a neutral background
(white, black, or a color that does not contrast with those employed in the heat map).
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Figure 5
Visualizations of single-cell RNA sequencing observations of liver bud development. (a) Clustered heat map for the top 10 differentially
expressed genes in two cell types, indicated in the Sankey diagram with black and beige coloring. Saturation encodes absolute
expression, and row and column positions encode genes and experimental conditions, respectively. Genes and cells with similar
expression patterns are clustered to optimally order rows and columns. The cluster tree graph shows three distinct groups of expression
behavior, and vertical space has been inserted to separate these sets of rows. The Sankey diagram highlights imperfect separation of the
two cell types, and spaces have also been inserted to separate sets of differently behaving cells. In panels b–d, scatterplots show
alternative views created by applying dimensionality reduction methods, each revealing different aspects of the full data set. (b) PCA
groups most cell types but does not resolve cells forming the definitive endoderm and the hepatic endoderm. (c) t-SNE (126) provides
more insight, revealing local similarities as well as overall variation in the data set. However, t-SNE can be more difficult to apply, as it
requires setting a manually adjustable parameter (perplexity) (127). (d ) Diffusion maps (128, 129) model relationships between points in
the data set as a diffusion process that is then reduced to a lower-dimensional map. Here, successive developmental relationships
between cells are revealed. Panel a was made using R and D3.js (Sankey diagram). Panels b–d were made using scater (130). All panels
were modified using Illustrator. Data in panels a–d are from Reference 131 and reanalyzed in R with read counts processed, as described
by Hemberg et al. (https://github.com/hemberg-lab/scRNA.seq.course). Abbreviations: IPSC, induced pluripotent stem cell; PCA,
principal component analysis; t-SNE, t-distributed stochastic neighborhood embedding.
reduction heuristics (49) allow pseudotime to be inferred, visualized, and quantitatively analyzed
(Figure 5d).
Single-cell transcriptomics measurements will soon become possible at the whole-organism
level (50), and we will undoubtedly require more effective methods for interpreting these data.
However, the measures of abundance obtained from these experiments are only markers that
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AN EXEMPLARY BIOMEDICAL DATABANK
Compared with many areas of biomedical science, visualization methods for macromolecular structures are more
advanced, largely because they build upon a solid bedrock of exceptionally well managed data. Created in 1972, the
Protein Data Bank (PDB; 51) has exemplary practices and stability that facilitate reproducibility and substantially
simplify the difficult task of creating and maintaining tailored visualization tools. In particular, (a) each entry is a
deposition related to one specific scientific publication, not to an abstract concept (e.g., a gene or pathway) whose
definition may change over time. (b) Entry identifiers are short and designed to be easy to remember. Depositors
can propose an identifier, ensuring that many are meaningful. For example, the first crystal structure of the protein
actin has identifier “1ATN” (114). (c) Entries include rich metadata describing how they were generated (and by
whom), as well as cross-linking to related databases. (d ) Raw and processed data are stored, enabling later reanalyses.
(e) An international network of organizations maintains and curates the database. ( f ) PDB deposition is required
when publishing in major journals.
Unfortunately, most biomedical databanks created since have not learned from these practices, thus requiring
tool developers to contend with data formats and sources that are many, varied, and often unstable.
indicate which parts of an organism’s genome are active. To understand the biological role each
gene plays, we must look beyond sequencing data; in fact, much of our current understanding has
come from studying the molecular structure of RNA transcripts and the proteins they encode.
Protein Structures
Protein structural biology aims to provide a detailed understanding of life’s molecular machinery.
Thanks to decades of research worldwide, we now have 3D molecular structures (at or near atomic
resolution) for ∼40,000 proteins. By viewing these structures, researchers can gain insight into
precise molecular mechanisms underlying many of the biochemical processes occurring within
living cells. Remarkably, almost all these structures are collected in a single, exemplary database
(https://www.wwpdb.org; 51) (see the sidebar titled An Exemplary Biomedical Databank). This
has helped drive innovation in molecular graphics, which has outpaced visualization advances in
many other areas of biomedical science (22).
Visualization challenges. Visualization is integral to structure determination and validation (22),
as well as for gaining insight into protein function (e.g., with tools such as Chimera and others;
22, 52, 53). A core challenge is conveying the many different features of these large, complex
data sets; this requires careful use of visualization principles (e.g., overview/details), judicious and
minimal use of color, and visually expressive representations to highlight specific aspects of the
data (Figure 6a–b).
Another challenge is conveying the complex 3D shape of proteins. In special cases, shape can
be communicated through specifically tailored 2D visualizations (Figure 6c), but ultimately, pro-
tein structures need to be viewed in three dimensions. For this reason, structural biology has
been an early adopter of new visual techniques, starting with physical models (used in solving
the first protein structures; 54), stereoscopic imaging (55), and virtual reality (VR) (56).2 This
has continued, with techniques such as low-cost VR (e.g., Visual Molecular Dynamics supports
Oculus Rift; 57), very-low-cost VR (e.g., Autodesk Molecule Viewer supports Google Cardboard;
2VR can focus undivided attention on a data set. Although powerful, usage is limited by inconvenience, discomfort, motion
sickness, and other drawbacks. By contrast, augmented reality has fewer drawbacks and looks likely to become widespread in
biomedical research and in normal life.
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Visualizations of protein structure data. (a) Advances in web molecular graphics now allow structures with millions of atoms to be
interactively explored on a smartphone. Surface representations (shown here) and space-fill representations are useful for overviewing
the arrangement of individual proteins in larger assemblies. (b) For a detailed view of a single protein, ribbon representation is useful
(132), revealing how polypeptide chains fold in three dimensions; this is helped by linking to a sequence view (d ). Using
semitransparency for other chains in the structure can provide supporting context without clutter. Highlighting conserved or
nonconserved amino acid differences to the wild-type sequence of interest gives a visual indication of model reliability (133). Typically,
many such differences occur in structures inferred via homology modeling; but they are also common in Protein Data Bank (PDB)
structures due to experimental limitations. (c) In special cases (e.g., GPCR transmembrane proteins, shown here), simplified
two-dimensional (2D) schematics can be used to show overall topology as well as details, such as loop regions or residues where
mutations have large functional effects (encoded using numbering and coloring, respectively). (d ) A schematic representation of a
full-length, wild-type protein sequence, with coloring indicating regions with significant sequence similarity to structures in the PDB.
Details on these matching structures can be revealed upon demand using a tree graph. On average, each protein sequence matches to
∼200 PDB structures (63) but contains several dark regions, with no detectable similarity to any known 3D structure (66). (e) A stacked
bar chart showing the total fraction of protein residues that map to any PDB structure (either directly or via homology modelling); the
remaining fraction (dark proteome) is divided into dark regions (d ) and dark proteins (where a single dark region spans an entire
sequence) (66). Stacked bar charts have been used to achieve moderate data density, and axes replaced by two shaded regions (indicating
25%, 50%, and 75%). Connecting lines facilitate comparison. ( f ) A scatterplot of darkness versus disorder (134) for ∼180,000
eukaryotic proteins. Point size, color, and transparency have been adjusted to reveal an unexpected overall pattern (darkness exceeds
disorder for most proteins, indicating that much of the dark proteome is not explained by disorder). Due to high data density, subtle
patterns are also revealed (e.g., horizontal streaks arising from related sequence families). Panel a was made using NGL Viewer
(https://www.rcsb.org/pdb/ngl/ngl.do?pdbid = 3J3Q; 135) with PDB 3J3Q (136) and a stock photo from Unsplash, panels b and d
were made using Aquaria (http://aquaria.ws/O75333/4a04/, 63) and Photoshop with PDB 4A04 (137), panel c was made using data
from GPCRdb (138), and panels e and f were made using ggplot2 (116) with data from Reference 139. All images were modified using
Illustrator.
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https://www.molviewer.com/), 3D printing (58), commodity interaction devices (e.g., Leap Mo-
tion and Kinect; 59), augmented reality (AR) (60), crowdsourced evaluations (61), concepts from
computer gaming (62), and emerging web technologies (e.g., WebGL; see Figure 6a).
Emerging frontiers. Protein structural biology is still far from complete, as many proteins still
have little or no experimentally determined structural information. To address this, researchers
are using high-throughput homology modeling to systematically compare all known protein se-
quences against all experimentally determined structures, resulting in over 100 million model
structures (63). Allowing researchers to effectively explore and benefit from such large data sets
requires carefully tailored visualization tools (63) that use the overview/details strategy, as well
as alternative views connected via brushing and linking (Figures 6d,e) (64). Homology model-
ing currently provides structural models for about half of the eukaryotic proteome (Figure 6e).
Interestingly, much of the remaining dark proteome currently cannot be explained (e.g.,
Figure 6f ). Exploring this dark protein structure universe is an important data science challenge
(65) in which visualization is playing a key role (66).
High-throughput approaches are also being applied to molecular dynamics (67), generating
increasingly large, complex trajectories; these data can give insights into key events (e.g., binding
with ligands or other proteins). However, unearthing those insights is a still major challenge,
requiring further innovations to create very specific, tailored visualization tools (e.g., 22, 52, 57).
In addition, rapid advances in cryo-electron microscopy are making accessible much larger
structures and molecular assemblies than ever before (68); this has promoted improvements in
methods for visual exploration of multiscale molecular data (http://ncbr.muni.cz/LiteMol). Fi-
nally, high-throughput computing is also being used to integrate structural data in the construction
of atomic-scale models of viruses, subcellular compartments, or even whole cells (69). The scale
and complexity of these models requires the development of radically new visualization methods,
bridging structural and systems biology (70).
Systems Biology
We have long speculated how biomolecules coordinate to perform cellular function (71),
and graph-based visualizations have been key to organizing our thoughts (23). An exem-
plar is the Roche metabolic pathway (Figure 7a), initiated by Gerhard Michal in 1965
(http://biochemical-pathways.com/; 72); this manually tailored visualization shows thousands
of metabolic reactions in a single, comprehensive view. Such pathway graphs have endured be-
cause they are visually expressive, showing causal flow and providing insight into molecular events
underlying health and disease.
Visualization challenges. Over 4 billion biochemical reactions are currently known, and this
number is rising rapidly (73). These data are typically visualized with specialized tools [e.g., Cy-
toscape (74) or Gephi (75)] that provide a range of automated layout methods, many based on
force-directed algorithms (76), resulting in network graphs (Figure 7b). A force-directed lay-
out (also known as spring embedding) can be useful for overviewing a data set; however, even
small biological networks are often so interconnected that these graphs become overly cluttered
(Figure 7b). Force-directed layout is so common that it has become something of a limiting
paradigm, often used even when better strategies are available.3 For example, when integrating
connectivity with other data (e.g., time, subcellular location), the go-to strategy has been to overlay
3Overreliance on familiar tools can lead to cognitive bias: Paraphrasing a popular adage, if your only tool is spring embedding,
every data set looks like a network graph.
www.annualreviews.org • Visualization of Biomedical Data 289
Review in Advance first posted on 
May 14, 2018. (Changes may still 

























































































BD01CH13_ODonoghue ARI 25 April 2018 15:4
KIF18A S-684
KIF18A is phosphorylated by CDK1 at S-674 and S-
684, which facilitates chromsosome movements during 




































c  Profile plots
b  Network graph
Excretory/end products
Compounds
+ Positive regulation 































































(Caption appears on following page)
290 O’Donoghue et al.
Review in Advance first posted on 
May 14, 2018. (Changes may still 

























































































BD01CH13_ODonoghue ARI 25 April 2018 15:4
Figure 7 (Figure appears on preceding page)
Pathway and network graphs of molecular systems. (a) Part of an exemplary tailored visualization; the full pathway shows causal flow
involving ∼3,000 reactions, plus supporting context (e.g., molecular structures). Note the effective use of visual channels (Figure 2).
Position and shape show reaction categories, while minimal coloring is used to show—without clutter—different versions of the pathway
for four categories of organisms. (b) Network graphs created via spring embedding are common (here, edge width encodes interaction
confidence scores) but often too cluttered. This can be partly mitigated via, e.g., edge bundling (78). (c) The first step in visualizing
phosphoproteomics data is to identify clusters of phosphosites with similar time profiles (thin light-blue lines). Clusters are modeled as a
series of phosphorylation (solid arrows) and dephosphorylation (dashed arrows) events, each arising from a specific kinase or phosphatase
(140) and occurring when the average phosphorylation (thick blue line) passes 50% ( yellow dotted line). (d ) A tailored visualization for
phosphoproteomics data, where selected proteins are drawn as tracks in a circtangular cellular landscape. Position encodes subcellular
location (with translocations shown as excursions from the track layout) and the temporal ordering of phosphoevents, each indicated via
an arrow connecting a kinase or phosphatase to its substrate site. Color hue shows events that perform coordinated functions. Texture
is used show context, such as membranes. An online version has further interactive features (e.g., informative popups, motion,
highlighting upon hover) that help researchers use these complex data sets to gain insight into cellular processes, such as insulin
response (85) or mitosis (86). Panel a was redrawn with permission from http://biochemical-pathways.com/ (72); panels b–d were
made using STRING (141), Matplotlib (115), and Minardo (https://minardo.org; 86), respectively, and modified using Illustrator.
these data onto existing network layouts (23), thus reducing visual effectiveness due to clutter. Of-
ten, it is better to change the layout entirely, using position (the most effective visual channel for
quantitative data; see Figure 2) to encode not just connectivity but also biological context that
helps in interpreting data. This approach is taken in several tailored visualization tools, such as
Cerebral (77), which uses position to encode subcellular location, edge-bundling to reduce clutter
(78), and small multiples for different conditions (79).
Visually expressive layouts (e.g., Cerebral) need to be tailored for each specific scenario, and
there are vastly many distinct scenarios in systems biology, since reactions vary greatly with cell
type, timing, and molecular microenvironment (80). Thus, many tailored visualizations have al-
ready been developed (23, 30), and unfortunately, systems biology data are fragmented across ∼700
resources (http://pathguide.org; 73), which partly impedes progress in the field. To help manage
the many complexities of these data, researchers use a wide range of visual techniques; for example,
the overview/detail strategy is used to allow subgraphs to be collapsed or expanded upon demand,
thus helping users more effectively explore large graphs. However, there remains considerable
scope for using visualization principles to design new, automated layouts (81, 82) and to improve
the computer-aided design of manual layouts. There is also considerable scope for improving how
systems biology data are organized (see the sidebar titled An Exemplary Biomedical Databank).
Emerging frontiers. Mass spectrometry–based proteomics (83, 84) is a rapidly emerging tech-
nology that enables systematic measurement of proteome-wide posttranslational modifications in
response to stimuli, such as phosphorylation (termed phosphoproteomics). These technologies are
providing new insights into fundamental cellular processes and diseases, which in turn may lead
to new therapeutic interventions. However, there is a price: increased complexity. Each phospho-
proteomics experiment can track highly dynamic changes in over 10,000 different phosophosites
in over 5,000 proteins (84). In analyzing these data sets, it is common to first identify coregulated
phosophosites, based on clustering of time profiles (Figure 7c). Several tailored visualization
strategies are being developed for exploring these clusters. In one, inspired by the cyclic journey
in Minard’s exemplary chart (Figure 3e), the cascade of phosphorylation events is laid out as a
cyclic journey through a cellular landscape (Figure 7d). Proteins are represented as tracks and
phosphoevents are positioned by time and subcellular location—two key variables in these experi-
ments. This layout facilitates spatial reasoning about causal relationships, helping researchers use
these complex data sets to gain insight into cellular processes, such as insulin response (85) or
mitosis (86).
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These and other advances in molecular systems biology promise to revolutionize medicine.
However, realizing this promise will require software platforms capable of bridging scales, from
molecules to cells, tissues, and whole organisms—a formidable challenge in which visualization
plays a central role (70).
Cellular and Tissue Imaging
Imaging remains the primary way that we observe biological systems. Quantitative imaging data are
employed throughout the biomedical sciences as a basis for research, diagnosis, and therapy. Since
van Leuwenhoek created the first microscope, biologists have observed the structure and behavior
of cells and how they form tissues and develop into organisms. Most recently, technological
advances in labeling, sample handling, and imaging have expanded microscopy’s capabilities (87),
and we are now able to image complex cellular assemblies, such as neurons, in three dimensions or
capture in real time the cellular processes that drive development (88). Imaging has also advanced
in medicine, allowing detection and diagnosis of pathologies and providing essential guidance
before and during surgery.
Visualization challenges. Imaging data can give quantitative and qualitative insights into mor-
phology and function; however, this often requires extensive and sophisticated processing pipelines
(89). An increasing array of tools are being developed to address this need, some of which now
allow interactive visualization of raw images together with image-derived data, e.g., the Medical
Imaging Interactive Toolkit (http://mitk.org/) and Slicer (http://www.slicer.org/). The primary
way that we interpret these image-derived data is by encoding them as colors and annotations that
are then overlaid onto the original images. This presents a challenge because biological images
are usually already very complex; thus, detail often needs to be removed from the original im-
age (for example, by transforming the image’s dynamic range or color space) before derived data
can be overlaid for either data exploration or publication. While many image processing and fig-
ure generation tools allow these operations, such manipulations may obscure critical details and
therefore need to be documented in a reproducible manner. There is broad consensus that the
transformation of image data needs to be better reported in scientific publications (90). Recent
advances (91) are beginning to address these issues, allowing interactive creation of figures for
online publication (Figure 8a) that link to original data (e.g., high-content screening, time-lapse
or histological whole-slide imaging data) and to metadata (related to experimental design, image
acquisition, analysis, and interpretation), thus allowing subsequent reanalysis.
Emerging frontiers. An exciting frontier in medicine is the use of AR (92) to enhance, for
example, live video feeds used to guide surgery with preoperative, diagnostic imaging data
(Figure 8b). This approach promises to reduce error and increase precision during surgery by
providing real-time guidance about the location and physiological status of diseased tissue. Once
again, visual complexity is a major challenge; however, by integrating machine learning and se-
mantic modeling approaches (93), surgeons today have already begun to use AR to see beyond the
capabilities of normal visual perception.
There remains tremendous opportunity for improving the integration of advanced analytic
tools with interactive visualization, creating new platforms, such as the Allen Cell Explorer
(http://www.allencell.org/). Soon such improvements are set to greatly advance our understand-
ing of the composition, structure, and dynamics of normal and pathological cells and tissues, as
well as the effectiveness and precision of medical interventions.
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Figure 8
Cellular and tissue imaging. (a) Multipart, annotated image created from, and linked to, raw data sets. By
automating many routine manual tasks involved in creating well-formatted, publication-ready figures, tools
such as OMERO. figure enable scientists to scale-up, easily creating figures with higher data density, and
thus to address more complex questions. Figure panels can be rendered dynamically from the original image
data and automatically overlaid with timestamps and scale bars, avoiding potential human error. Such tools
can document all steps from the original image files to the final figure, improving data integrity,
organization, and provenance. (b) Augmented reality imaging in minimally invasive surgery. Before the
intervention, target and critical structures are segmented in a three-dimensional (3D) planning image. At the
beginning of surgery, artificial navigation aids (fiducials) are inserted into the target organ (here, prostate),
and their 3D configuration is determined from a 3D intraoperative medical image (e.g., a 3D transrectal
ultrasound image). The latter is fused with the preoperative planning image using a 3D/3D registration
algorithm. During surgery, the fiducials are continuously tracked in the 2D video images, and a 2D/3D
registration algorithm (142) is used to find a transformation relating the endoscopic camera coordinate
system with the image coordinate system of the 3D intraoperative modality. This enables the laparoscopic
video image acquired during prostatectomy to be overlaid in real time with the prostate capsule and critical
structures. Panel a was made using OMERO. figure (http://figure.openmicroscopy.org/demo/#file/1; 91)
with data from Reference 143. Panel b was made using the Medical Imaging Interaction Tool Kit (144), with
data from Reference 145.
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Populations and Ecosystems
Some of the most compelling questions in biology center on how our genome affects how we live
and interact with other organisms and our environment and how these interactions change over
time. Tree graphs (Figure 9a) are the primary way we visualize ancestral relationships between
organisms. With sufficient data, trees can convey not only evolutionary distance but also the order
in which different lineages may have evolved. Genomic sequence comparisons allow us to infer
how species or individuals within a population differ from one another, but these contain localized
features (e.g., SNPs, indels), copy number variants, and rearrangements that extend over millions
of bases. Parallel coordinate plots (Figure 9b) provide one way of viewing multiple alignments of
closely related bacterial genomes. These visualizations highlight the changes in genomic regions
or even individual genes as they undergo mutation, rearrangements, or horizontal gene transfer.
Visualization challenges. Phylogenetic tree and comparative genomic visualizations are rela-
tively mature (20, 30). For metagenomics and population sequencing, however, neither represen-
tation will suffice. Here, interactive plots or static visualizations at multiple scales are needed to cap-
ture the breadth and depth of these data. Branch structures in phylogenetic trees quickly become
illegible in the presence of large sets of taxa (Figure 9a), so important differences in lineage must
be manually highlighted. In biome analysis, the main objective is to determine the composition
of samples (Figure 9c) and how they change and evolve over time. Stacked bar charts (Figure 9c)
allow broad differences in composition to be shown, but it is important to also show lineage.
This is often done with sunburst plots (Figure 9d), although using flame graphs instead makes it
easier to compare multiple plots (Figure 9e). Similarly, the Venn diagrams (Figure 9f ) typically
used to visualize species co-occurrence can often be replaced by linear diagrams (Figure 9g).
Overall, there remains considerable scope for improvements—for example, with many of the cur-
rent tools in this research area, considerable effort is required when using them to create figures
for publication that are uncluttered, effective, and visually expressive.
Emerging frontiers. Advances in genomic sequencing allow us to examine differences within
populations and across ecosystems in unprecedented detail. A plethora of microbiome sequence
data promises to revolutionize our understanding of evolution and human health. But we are
struggling to develop effective visual analysis strategies because no single visual metaphor cap-
tures the richness of population-level data. Pan-genome visualizations, designed to show core and
accessory genes in a species’ genome, are dashboards that combine existing methods (94). Phylo-
geography uses maps to show phylogenetic relationships across geocoded samples (95). Pathogen
surveillance, a crucial challenge that spans these fields, requires integrated, alternative views that
capture population dynamics and highlight emerging resistance (96).
Our ability to observe biology at the molecular, cellular, anatomical, and physiological levels has
never been greater, but making sense of these emerging data will require overcoming formidable
analytical challenges, as well as the invention of fundamentally new visual metaphors (97), changing
how we see and think about our data.
VISUALIZATION FOR COMMUNICATION
Science is not complete until it is communicated (Figure 1a); however, this is often challenging
due to the inherent complexity of biomedical research. Fortunately, visualization can help here as
well.
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Figures and Illustrations
In preparing a publication, visualization tools used for discovery are typically used to select static
views that best express the insights found. A very small number of journals allow interactive figures;
unfortunately, interactive figures in publications are often complex to produce and difficult to
maintain – and, ironically, are used by very few readers. Interactive figures can augment static
figures, but not replace them: just as scientific writing commits us to a particular way of describing
our work, a static view commits us to a particular viewpoint that we believe best expresses the
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Figure 9 (Figure appears on preceding page)
Phylogenetic, comparative genomic, and metagenomic data visualizations. (a) A phylogenetic tree showing evolutionary relationships
and inferred operational taxonomic units (OTUs) for 16S amplicon sequencing data. While commonly used, phylogenetic trees
have drawbacks: Closely related taxa become hard to resolve, and as their numbers increase, topological relationships quickly become
obscured, even with the application of semantic zooming (used here to omit overlapping labels on adjacent branches). The tree contains a
total of 761 leaves of which ∼50 have a named OTU. (b) A multiple-genome alignment viewed as a parallel coordinate plot, with a zoomed
region on a Shigella flexneri genome. Each genome is represented as a linear axis. Connecting lines between genomes indicate conserved
regions. Lines that do not intersect with some genomes indicate horizontal gene transfer, and convergent and divergent lines correspond
to gene duplication and inversion events between S. flexneri and the three Escherichia coli strains. The zoomed region of the S. flexneri
genome reveals regions of divergence in an otherwise conserved part of the alignment. Colors are assigned to aligned sections of each
genome, and a similarity profile is overlaid as a line graph in a more saturated color. When genes are inverted in some organisms, the area
is shown below the genome axis. (c) Species abundance (or beta diversity) visualized as a stacked bar chart for a metagenomics analysis of
microbiome samples taken from different parts of the body. Colors encode phyla of identified OTUs in samples. These charts are useful
for comparing abundance across broad taxonomic levels (as shown here) but become too complex when used to show the ∼280 species
in each sample (zoomed region). (d ) Sunburst plots showing beta diversity for pooled samples from two body sites. While these accurately
portray lineage relationships, it can be difficult to compare multiple plots. (e) Flame graphs encode taxonomic rank as height and
abundance as width, making it easier to compare plots and to see where taxonomic assignment is incomplete. ( f ) Species co-occurrence
among samples from the four sites shown as a Venn diagram. Many tools offer advanced layout and shading models for Venn diagrams but
can result in plots that are not visually effective. ( g) A linear diagram of the same data, using the x-axis to show the number of co-occurring
species between tissues and gray vertical boxes to highlight intersections. Panel a was made using Archaeopteryx (146), b using
Mauve (147), c using QIIME2 (148), d and e using QuanTiTree (http://metasystems.riken.jp/visualization/quantitree/index.htm),
f using the R Venn library (https://cran.r-project.org/web/packages/venn/index.html), and g using the Linear Diagram
Generator (149). All panels were modified using Illustrator. Data in panels a and c–g are from the moving pictures data set (150).
phenomena revealed by our data. Although difficult, selecting static views is often an essential step
in research – and can lead to new insights.
In many cases, these static views need to be postprocessed, using tools such as Illustrator or
Photoshop, to improve clarity and ensure that marks and labels are consistent and readable at
publication scale. In addition, since ∼5% of readers and reviewers are colorblind (98), it is good
practice to use color blindness proofing tools4 and, where needed, modify figures to avoid relying
on red-green contrast – this can usually be achieved by adjusting saturation and lightness values
to increase contrast (98).
However, it sometimes can be unclear where the boundary lies between necessary improve-
ments versus scientific fraud; thus, it is important to follow established guidelines on image and
figure manipulation (99).
Animations and Videos
Animations and videos can dramatically enhance scientific communication and are becoming eas-
ier and cheaper to produce, leading to a marked increase in scientific video content (100). Done
well, scientific videos improve peer-to-peer communication and inspire public engagement and
enthusiasm (27). Unfortunately, ensuring scientific accuracy typically involves considerable time
and effort, as does achieving a high standard in video production, which requires learning cine-
matography principles, practices, and tools (e.g., Autodesk Maya, Blender, Adobe After Effects).
To help overcome these barriers, researchers are developing several specialist tools to stream-
line and simplify the production of scientific animations (101). Unfortunately, until these efforts
become more advanced, accurate and compelling scientific videos will likely remain relatively rare.
4In Illustrator and Photoshop, choose the menu items View > Proof Setup > Color Blindness to preview how a figure will
appear to people with common forms of color blindness.
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PERSPECTIVES
This review has highlighted a few specific cases where data visualization is being used to accelerate
discovery, but biomedical science has thousands more. Thus, while many visualization tools are
already available (1, 20–24, 30), they are often inadequate for cutting-edge data sets. Addressing
this challenge requires the invention of novel, tailored visualization strategies, each adapted to
specific scenarios; this can be very difficult and, in many cases, is a rate-limiting step in discovery.
The resources outlined in this review can help (particularly Table 1). Especially noteworthy
resources include the 2010 Nature Methods special issue on visualizing biological data (1, 20–24)
and the ongoing Nature Methods Points of View article series focused on specific visualization
issues for life scientists (6). It can also be useful to exchange experiences with peers facing similar
challenges. The annual Visualizing Biological Data (VIZBI) conference provides a forum for
this exchange and provides a free online collection of videos and posters from previous meetings
(http://vizbi.org/). The VIZBI forum is also designed to help bioinformaticians connect with
graphic designers, graphic artists, and biomedical communicators using illustration or animation.
It can also help to connect with computer scientists researching data visualization; as well as
advising on good principles and practice, they can be valuable collaborators. A forum for such
engagement is provided by the annual BioVis Symposium (http://biovis.net/).
Tailored visualization tools play a critical role in research, some becoming widely used and
highly cited (102). However, limitations in popular tools (e.g., cluttered, overly complicated user
interfaces or poorly chosen defaults, such as rainbow color maps; 10) can have very negative
impacts, contributing to dead-end research and incorrect diagnoses. Creating tailored tools with
good visualization and design practices (103) typically requires years of sustained focus. It is often
not clear how tool development and maintenance can be funded; however, it is clear that this
needs to be a central issue in research funding policies.
This review has highlighted that specific research areas need highly tailored visualization tools;
nonetheless, there are common generic methods (e.g., tree graphs, parallel coordinates, stacked bar
charts) and strategies (e.g., clustering, alternative views, overview/details, linked views, minimal
coloring) being used across many research areas. There are also common outstanding challenges,
such as uncertainty visualization (104) and multiscale navigation. Unfortunately, some poor vi-
sualization practices are also common (e.g., overly cluttered visualizations). However, there are
good indicators that this situation is improving and that there is increased awareness of the im-
portance of data visualization in the life sciences (105). This is evidenced by the increased focus
on visualization in mainstream conferences, as well as the emergence of more specialist meetings,
such as VIZBI and BioVis.
As we seek to improve our tailored visualizations, another common challenge is how to ob-
jectively assess the quality of a particular visualization method or tool (106). An obvious and
important quality measurement is rate of adoption by the community; however, the popularity
of a visualization strategy often has more to do with the cognitive load required to first learn
how to read it, rather than how effectively or expressively it allows data to be understood and
new insights to be generated. Here again, data visualization research can help. Methods are being
developed for quantitatively evaluating the effectiveness of visualizations (107) and for assessing
visual information processing—for example, via eye-tracking (108) or brain activity measurements
to assess cognitive load (109). Hopefully, these evaluation methods will soon provide objective
measures of the value of a visualization (106) that are recognized and agreed upon by the research
community. Together with other advances in data visualization and user experience design (103),
this may soon provide a new generation of tools that are much more powerful yet also easier to
learn and use. Such tools would significantly reduce many of the current frustrations of scientists
and clinicians and revolutionize how we see and think about our data.
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To understand and gain insight from the large, complex data sets generated in biomedical
research, we need tailored visualization methods and tools that present the right data and analysis to
the right researcher or clinician at the right time, providing a clear view of the inherent complexity
in our data, not the complication of oversimplification (paraphrased from Reference 5, p. 191).
The development and adoption of such methods and tools will require fundamental changes to
current research, communication, training, and clinical practices. Without these changes, many
biomedical insights will remain undiscovered and misdiagnoses will remain unrecognized, buried
in data already collected.
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